annual operating profit:
$10.00B+$1.28B(+14.69%)Summary
- As of today (April 13, 2025), AZN annual operating income is $10.00 billion, with the most recent change of +$1.28 billion (+14.69%) on December 31, 2024.
- During the last 3 years, AZN annual operating profit has risen by +$10.14 billion (+7296.40%).
- AZN annual operating profit is now -13.41% below its all-time high of $11.55 billion, reached on December 31, 2010.
Performance
AZN Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$2.04B-$70.00M(-3.32%)Summary
- As of today (April 13, 2025), AZN quarterly operating income is $2.04 billion, with the most recent change of -$70.00 million (-3.32%) on December 31, 2024.
- Over the past year, AZN quarterly operating profit has stayed the same.
- AZN quarterly operating profit is now -54.97% below its all-time high of $4.52 billion, reached on March 31, 1999.
Performance
AZN quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$10.00B-$755.00M(-7.02%)Summary
- As of today (April 13, 2025), AZN TTM operating income is $10.00 billion, with the most recent change of -$755.00 million (-7.02%) on December 31, 2024.
- Over the past year, AZN TTM operating profit has stayed the same.
- AZN TTM operating profit is now -23.62% below its all-time high of $13.10 billion, reached on September 30, 2011.
Performance
AZN TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
AZN Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | 0.0% | 0.0% |
| 3 y3 years | +7296.4% | +277.7% | +673.6% |
| 5 y5 years | +475.6% | +277.7% | +673.6% |
AZN Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7296.4% | -34.6% | +277.7% | -7.0% | +673.6% |
| 5 y | 5-year | at high | +7296.4% | -34.6% | +221.6% | -7.0% | +673.6% |
| alltime | all time | -13.4% | +7296.4% | -55.0% | +142.1% | -23.6% | +673.6% |
AstraZeneca Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $10.00B(+14.7%) | $2.04B(-3.3%) | $10.00B(-7.0%) |
| Sep 2024 | - | $2.11B(-23.3%) | $10.76B(+1.4%) |
| Jun 2024 | - | $2.75B(-11.8%) | $10.61B(+2.8%) |
| Mar 2024 | - | $3.12B(+11.6%) | $10.32B(+8.5%) |
| Dec 2023 | $8.72B(+93.3%) | $2.79B(+42.8%) | $9.51B(+10.2%) |
| Sep 2023 | - | $1.95B(-20.4%) | $8.63B(+9.0%) |
| Jun 2023 | - | $2.46B(+6.4%) | $7.92B(+31.9%) |
| Mar 2023 | - | $2.31B(+20.8%) | $6.00B(+31.3%) |
| Dec 2022 | $4.51B(-3346.0%) | $1.91B(+53.4%) | $4.57B(+289.1%) |
| Sep 2022 | - | $1.25B(+131.0%) | $1.18B(-167.4%) |
| Jun 2022 | - | $539.00M(-38.6%) | -$1.74B(+50.9%) |
| Mar 2022 | - | $878.00M(-159.0%) | -$1.16B(+731.7%) |
| Dec 2021 | -$139.00M(-103.5%) | -$1.49B(-11.2%) | -$139.00M(-108.7%) |
| Sep 2021 | - | -$1.67B(-248.5%) | $1.59B(-64.2%) |
| Jun 2021 | - | $1.13B(-40.5%) | $4.43B(-3.4%) |
| Mar 2021 | - | $1.90B(+686.3%) | $4.59B(+17.2%) |
| Dec 2020 | $3.92B(+125.3%) | $241.00M(-79.4%) | $3.92B(+27.7%) |
| Sep 2020 | - | $1.17B(-8.8%) | $3.07B(+15.6%) |
| Jun 2020 | - | $1.28B(+5.2%) | $2.65B(+42.5%) |
| Mar 2020 | - | $1.22B(-300.3%) | $1.86B(+7.1%) |
| Dec 2019 | $1.74B(+236.8%) | -$609.00M(-180.4%) | $1.74B(+384.1%) |
| Sep 2019 | - | $757.00M(+53.5%) | $359.00M(-30.3%) |
| Jun 2019 | - | $493.00M(-55.1%) | $515.00M(-34.4%) |
| Mar 2019 | - | $1.10B(-155.2%) | $785.00M(+104.4%) |
| Dec 2018 | $516.00M(-74.9%) | -$1.99B(-317.7%) | $384.00M(-73.2%) |
| Sep 2018 | - | $913.00M(+19.7%) | $1.43B(-14.1%) |
| Jun 2018 | - | $763.00M(+9.6%) | $1.67B(-8.8%) |
| Mar 2018 | - | $696.00M(-174.1%) | $1.83B(-10.8%) |
| Dec 2017 | $2.05B(-42.6%) | -$939.00M(-181.7%) | $2.05B(-51.1%) |
| Sep 2017 | - | $1.15B(+24.2%) | $4.19B(+3.0%) |
| Jun 2017 | - | $925.00M(+0.9%) | $4.07B(+18.0%) |
| Mar 2017 | - | $917.00M(-23.8%) | $3.45B(-3.4%) |
| Dec 2016 | $3.57B(+16.5%) | $1.20B(+17.0%) | $3.57B(+48.2%) |
| Sep 2016 | - | $1.03B(+239.3%) | $2.41B(-5.6%) |
| Jun 2016 | - | $303.00M(-70.8%) | $2.55B(-19.5%) |
| Mar 2016 | - | $1.04B(+2431.7%) | $3.17B(+3.4%) |
| Dec 2015 | $3.07B(+28.3%) | $41.00M(-96.5%) | $3.07B(+4.7%) |
| Sep 2015 | - | $1.17B(+26.8%) | $2.93B(+27.3%) |
| Jun 2015 | - | $923.00M(-1.1%) | $2.30B(-7.5%) |
| Mar 2015 | - | $933.00M(-1071.9%) | $2.49B(+4.1%) |
| Dec 2014 | $2.39B(-35.4%) | -$96.00M(-117.7%) | $2.39B(+27.0%) |
| Sep 2014 | - | $541.00M(-51.2%) | $1.88B(-38.2%) |
| Jun 2014 | - | $1.11B(+32.7%) | $3.05B(-2.9%) |
| Mar 2014 | - | $836.00M(-238.4%) | $3.14B(-15.2%) |
| Dec 2013 | $3.70B(-53.1%) | -$604.00M(-135.4%) | $3.70B(-38.4%) |
| Sep 2013 | - | $1.71B(+42.2%) | $6.00B(-7.0%) |
| Jun 2013 | - | $1.20B(-14.1%) | $6.45B(-9.4%) |
| Mar 2013 | - | $1.40B(-17.9%) | $7.12B(-9.7%) |
| Dec 2012 | $7.88B(-30.1%) | $1.70B(-21.1%) | $7.88B(+15.4%) |
| Sep 2012 | - | $2.16B(+15.4%) | $6.83B(-23.6%) |
| Jun 2012 | - | $1.87B(-13.5%) | $8.94B(-10.9%) |
| Mar 2012 | - | $2.16B(+231.8%) | $10.04B(-11.0%) |
| Dec 2011 | $11.28B(-2.4%) | $651.00M(-84.7%) | $11.28B(-13.9%) |
| Sep 2011 | - | $4.26B(+43.7%) | $13.10B(+16.5%) |
| Jun 2011 | - | $2.96B(-12.8%) | $11.24B(-0.6%) |
| Mar 2011 | - | $3.40B(+37.7%) | $11.31B(-2.1%) |
| Dec 2010 | $11.55B(+5.1%) | $2.47B(+2.6%) | $11.55B(+6.4%) |
| Sep 2010 | - | $2.41B(-20.7%) | $10.86B(-6.8%) |
| Jun 2010 | - | $3.03B(-16.7%) | $11.65B(+1.6%) |
| Mar 2010 | - | $3.64B(+105.6%) | $11.47B(+4.4%) |
| Dec 2009 | $10.99B(+20.2%) | $1.77B(-44.7%) | $10.99B(+1.3%) |
| Sep 2009 | - | $3.20B(+12.4%) | $10.85B(+6.6%) |
| Jun 2009 | - | $2.85B(-9.9%) | $10.18B(+2.5%) |
| Mar 2009 | - | $3.16B(+93.5%) | $9.93B(+8.6%) |
| Dec 2008 | $9.14B | $1.64B(-35.4%) | $9.14B(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $2.53B(-2.8%) | $8.83B(+4.3%) |
| Jun 2008 | - | $2.60B(+9.7%) | $8.47B(+3.1%) |
| Mar 2008 | - | $2.37B(+79.2%) | $8.22B(+1.5%) |
| Dec 2007 | $8.09B(-1.5%) | $1.32B(-38.9%) | $8.09B(-7.7%) |
| Sep 2007 | - | $2.17B(-7.7%) | $8.77B(+0.7%) |
| Jun 2007 | - | $2.35B(+4.3%) | $8.71B(+2.6%) |
| Mar 2007 | - | $2.25B(+12.4%) | $8.49B(+3.4%) |
| Dec 2006 | $8.22B(+26.4%) | $2.00B(-4.9%) | $8.22B(+4.7%) |
| Sep 2006 | - | $2.11B(-1.2%) | $7.85B(+5.5%) |
| Jun 2006 | - | $2.13B(+7.8%) | $7.44B(+5.9%) |
| Mar 2006 | - | $1.98B(+20.8%) | $7.03B(+8.0%) |
| Dec 2005 | $6.50B(+43.0%) | $1.64B(-3.5%) | $6.50B(+5.9%) |
| Sep 2005 | - | $1.70B(-1.3%) | $6.14B(+9.3%) |
| Jun 2005 | - | $1.72B(+18.2%) | $5.61B(+13.5%) |
| Mar 2005 | - | $1.45B(+14.3%) | $4.95B(+8.8%) |
| Dec 2004 | $4.55B(+13.5%) | $1.27B(+8.4%) | $4.55B(+13.1%) |
| Sep 2004 | - | $1.17B(+11.4%) | $4.02B(+2.0%) |
| Jun 2004 | - | $1.05B(0.0%) | $3.94B(+4.2%) |
| Mar 2004 | - | $1.05B(+41.2%) | $3.78B(-5.5%) |
| Dec 2003 | $4.01B(+0.0%) | $745.00M(-32.0%) | $4.01B(+0.3%) |
| Sep 2003 | - | $1.09B(+22.6%) | $3.99B(+4.8%) |
| Jun 2003 | - | $892.93M(-29.9%) | $3.81B(-4.3%) |
| Mar 2003 | - | $1.27B(+74.2%) | $3.98B(-0.6%) |
| Dec 2002 | $4.01B(-3.6%) | $731.21M(-20.0%) | $4.01B(-8.2%) |
| Sep 2002 | - | $913.79M(-14.1%) | $4.36B(-2.3%) |
| Jun 2002 | - | $1.06B(-18.0%) | $4.47B(+2.9%) |
| Mar 2002 | - | $1.30B(+19.0%) | $4.34B(+6.6%) |
| Dec 2001 | $4.16B(-7.1%) | $1.09B(+7.4%) | $4.07B(-12.8%) |
| Sep 2001 | - | $1.01B(+8.0%) | $4.67B(+2.1%) |
| Jun 2001 | - | $940.00M(-8.4%) | $4.57B(-0.8%) |
| Mar 2001 | - | $1.03B(-39.2%) | $4.61B(+3.0%) |
| Dec 2000 | $4.47B(+30.4%) | $1.69B(+83.7%) | $4.47B(+36.0%) |
| Sep 2000 | - | $918.66M(-5.8%) | $3.29B(+0.3%) |
| Jun 2000 | - | $975.39M(+9.4%) | $3.28B(-1.0%) |
| Mar 2000 | - | $891.85M(+77.0%) | $3.31B(-52.3%) |
| Dec 1999 | $3.43B(+41.3%) | $504.00M(-44.5%) | $6.94B(+332.0%) |
| Sep 1999 | - | $908.00M(-10.0%) | $1.61B(-47.0%) |
| Jun 1999 | - | $1.01B(-77.7%) | $3.03B(+12.0%) |
| Mar 1999 | - | $4.52B(-193.6%) | $2.71B(+350.0%) |
| Dec 1998 | $2.43B(+34.0%) | -$4.83B(-307.3%) | $601.10M(-36.5%) |
| Sep 1998 | - | $2.33B(+240.2%) | $946.31M(+32.3%) |
| Jun 1998 | - | $685.00M(-71.7%) | $715.51M(-69.1%) |
| Mar 1998 | - | $2.42B(-153.9%) | $2.31B(+6.1%) |
| Dec 1997 | $1.81B(-3.0%) | -$4.49B(-313.7%) | $2.18B(-44.2%) |
| Sep 1997 | - | $2.10B(-8.1%) | $3.91B(-5.2%) |
| Jun 1997 | - | $2.28B(0.0%) | $4.12B(+0.1%) |
| Mar 1997 | - | $2.28B(-182.8%) | $4.12B(+0.1%) |
| Dec 1996 | $1.87B(+11.1%) | -$2.76B(-219.2%) | $4.11B(+49.7%) |
| Sep 1996 | - | $2.31B(+1.5%) | $2.75B(+16.0%) |
| Jun 1996 | - | $2.28B(0.0%) | $2.37B(+405.5%) |
| Mar 1996 | - | $2.28B(-155.3%) | $468.49M(+126.2%) |
| Dec 1995 | $1.68B(+40.9%) | -$4.12B(-313.1%) | $207.09M(-40.2%) |
| Sep 1995 | - | $1.94B(+411.0%) | $346.28M(+111.0%) |
| Jun 1995 | - | $378.70M(-81.2%) | $164.08M(-89.9%) |
| Mar 1995 | - | $2.02B(-150.6%) | $1.62B(+12.5%) |
| Dec 1994 | $1.19B(+17.0%) | -$3.98B(-327.3%) | $1.44B(+2.1%) |
| Sep 1994 | - | $1.75B(-4.6%) | $1.41B(+18.0%) |
| Jun 1994 | - | $1.84B(0.0%) | $1.20B(+8.0%) |
| Mar 1994 | - | $1.84B(-145.8%) | $1.11B(+8.7%) |
| Dec 1993 | $1.02B(+7.9%) | -$4.01B(-361.2%) | $1.02B(-79.8%) |
| Sep 1993 | - | $1.54B(-12.1%) | $5.03B(+44.0%) |
| Jun 1993 | - | $1.75B(0.0%) | $3.50B(+100.0%) |
| Mar 1993 | - | $1.75B | $1.75B |
| Dec 1992 | $944.90M(-25.5%) | - | - |
| Dec 1991 | $1.27B(-2.9%) | - | - |
| Dec 1990 | $1.31B | - | - |
FAQ
- What is AstraZeneca annual operating income?
- What is the all time high annual operating profit for AstraZeneca?
- What is AstraZeneca annual operating profit year-on-year change?
- What is AstraZeneca quarterly operating income?
- What is the all time high quarterly operating profit for AstraZeneca?
- What is AstraZeneca quarterly operating profit year-on-year change?
- What is AstraZeneca TTM operating income?
- What is the all time high TTM operating profit for AstraZeneca?
- What is AstraZeneca TTM operating profit year-on-year change?
What is AstraZeneca annual operating income?
The current annual operating profit of AZN is $10.00B
What is the all time high annual operating profit for AstraZeneca?
AstraZeneca all-time high annual operating income is $11.55B
What is AstraZeneca annual operating profit year-on-year change?
Over the past year, AZN annual operating income has changed by +$1.28B (+14.69%)
What is AstraZeneca quarterly operating income?
The current quarterly operating profit of AZN is $2.04B
What is the all time high quarterly operating profit for AstraZeneca?
AstraZeneca all-time high quarterly operating income is $4.52B
What is AstraZeneca quarterly operating profit year-on-year change?
Over the past year, AZN quarterly operating income has changed by $0.00 (0.00%)
What is AstraZeneca TTM operating income?
The current TTM operating profit of AZN is $10.00B
What is the all time high TTM operating profit for AstraZeneca?
AstraZeneca all-time high TTM operating income is $13.10B
What is AstraZeneca TTM operating profit year-on-year change?
Over the past year, AZN TTM operating income has changed by $0.00 (0.00%)